The Psychedelic Path to Spirituality with Dr. Roland Griffiths
November 7, 2023 · 55 min
Why listen
A Johns Hopkins pioneer explains how psilocybin research is reshaping our understanding of consciousness and depression.
Enjoy the episode?
Subscribe to The Psychedelic Report
In this episode
- How psilocybin can produce mystical experiences with lasting psychological effects
- Why strain differences in psilocybin mushrooms matter for future research
- What the evidence actually shows about psilocybin as a depression treatment
- Where psychedelic therapy is headed with new compounds and approaches
About this episode
In this episode Dr. Dave Rabin had the privilege of speaking with the late Dr. Roland Griffiths, a renowned figure in the field of psychedelic science and medicine. Dr. Griffiths, who passed away on October 16, 2023, was a pioneer in the study of consciousness and the therapeutic potential of psychedelic medicines. Dr. Griffiths was the Director of the Center for Psychedelic and Consciousness Research at Johns Hopkins University School of Medicine, shares his journey into the field, driven by his interest in meditation and altered states of consciousness. His groundbreaking research on psilocybin, the active compound in magic mushrooms, is discussed, highlighting the profound effects it induces, including mystical experiences and psychological insights. Dr. Griffiths underscores the need for further research into the variations among different strains of psilocybin mushrooms and the future of psychedelic therapy, which may involve novel compounds and therapeutic approaches. This episode provides valuable insights into the potential of psilocybin mushrooms for depression treatment and the ongoing advancements in psychedelic medicine.- Web: https://hopkinspsychedelic.org/griffiths
- Twitter: https://twitter.com/DrDavidRabin
- Instagram: https://www.instagram.com/drdavidrabin
- Web: https://www.drdave.io/
Learn more about your ad choices. Visit megaphone.fm/adchoices

About The Psychedelic Report
Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr.
See all episodes →



